American Century Companies Inc. cut its stake in Hamilton Lane Inc. (NASDAQ:HLNE – Free Report) by 7.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 501,979 shares of the company’s stock after selling 40,670 shares during the quarter. American Century Companies Inc.’s holdings in Hamilton Lane were worth $71,342,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in HLNE. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in Hamilton Lane during the 1st quarter worth about $432,772,000. Champlain Investment Partners LLC bought a new stake in shares of Hamilton Lane during the first quarter valued at about $112,887,000. T. Rowe Price Investment Management Inc. increased its position in shares of Hamilton Lane by 63.4% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company’s stock valued at $189,555,000 after buying an additional 494,637 shares during the period. Nuveen LLC purchased a new stake in shares of Hamilton Lane in the first quarter worth about $24,334,000. Finally, Janney Montgomery Scott LLC lifted its holdings in shares of Hamilton Lane by 2,139.2% in the second quarter. Janney Montgomery Scott LLC now owns 103,360 shares of the company’s stock worth $14,690,000 after buying an additional 98,744 shares in the last quarter. 97.40% of the stock is currently owned by institutional investors.
Hamilton Lane Stock Down 0.5%
Shares of HLNE opened at $122.41 on Thursday. The firm has a market cap of $6.83 billion, a P/E ratio of 23.54 and a beta of 1.23. Hamilton Lane Inc. has a 1 year low of $111.98 and a 1 year high of $200.79. The stock has a 50 day simple moving average of $126.68 and a two-hundred day simple moving average of $143.59. The company has a debt-to-equity ratio of 0.29, a current ratio of 4.32 and a quick ratio of 4.32.
Hamilton Lane Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Friday, December 19th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.8%. The ex-dividend date is Friday, December 19th. Hamilton Lane’s dividend payout ratio is presently 39.13%.
Insider Activity
In other news, major shareholder River 5 Ltd French sold 150,000 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $146.51, for a total transaction of $21,976,500.00. Following the transaction, the insider directly owned 330,015 shares of the company’s stock, valued at approximately $48,350,497.65. This trade represents a 31.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Juan Delgado-Moreira acquired 8,000 shares of the firm’s stock in a transaction dated Friday, November 7th. The stock was bought at an average price of $130.35 per share, for a total transaction of $1,042,800.00. Following the acquisition, the chief executive officer owned 1,314,447 shares of the company’s stock, valued at approximately $171,338,166.45. This trade represents a 0.61% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 22.21% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Morgan Stanley reduced their price objective on shares of Hamilton Lane from $169.00 to $154.00 and set an “equal weight” rating for the company in a research note on Tuesday, October 21st. The Goldman Sachs Group raised shares of Hamilton Lane from a “neutral” rating to a “buy” rating and set a $165.00 price target for the company in a report on Thursday, November 6th. Wall Street Zen raised shares of Hamilton Lane from a “sell” rating to a “hold” rating in a report on Sunday, November 9th. BMO Capital Markets began coverage on Hamilton Lane in a research report on Friday, October 3rd. They issued an “outperform” rating and a $150.00 price objective on the stock. Finally, Zacks Research lowered Hamilton Lane from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $159.29.
Read Our Latest Research Report on Hamilton Lane
Hamilton Lane Profile
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Stories
- Five stocks we like better than Hamilton Lane
- What is the NASDAQ Stock Exchange?
- Why Gold Loves Trump as Much as Trump Loves Gold
- Using the MarketBeat Stock Split Calculator
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- P/E Ratio Calculation: How to Assess Stocks
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Want to see what other hedge funds are holding HLNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hamilton Lane Inc. (NASDAQ:HLNE – Free Report).
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.
